A meta-analysis pooling both phases of our UK-GWA study with data from two other studies: IARC-GWA study of 1,989 cases and 2,625 controls(2), summary data from which is publicly available; Texas-GWA study of 1,154 non-small cell lung cancer (NSCLC) cases who were all smokers and 1,137 smoking matched controls(4). Comprehensive details of case and control ascertainment and matching criteria, as well as the genotyping of Texas-GWA and IARC-GWA studies have been published previously(2, 4).
